Cargando…

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis

Clusterin (CLU) is a stress‐activated molecular chaperone that confers treatment resistance to taxanes when highly expressed. While CLU inhibition potentiates activity of taxanes and other anti‐cancer therapies in preclinical models, progression to treatment‐resistant disease still occurs implicatin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al Nakouzi, Nader, Wang, Chris Kedong, Beraldi, Eliana, Jager, Wolfgang, Ettinger, Susan, Fazli, Ladan, Nappi, Lucia, Bishop, Jennifer, Zhang, Fan, Chauchereau, Anne, Loriot, Yohann, Gleave, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931290/ https://www.ncbi.nlm.nih.gov/pubmed/27198502 http://dx.doi.org/10.15252/emmm.201506059

Ejemplares similares

Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survival
por: Zhang, Fan, et al.
Publicado: (2014)

Regulation of mitosis and taxane response by Daxx and Rassf1
por: Giovinazzi, Serena, et al.
Publicado: (2011)

Androgen receptor (AR) antagonism triggers acute succinate‐mediated adaptive responses to reactivate AR signaling
por: Saxena, Neetu, et al.
Publicado: (2021)

Loss of Nuclear Functions of HOXA10 Is Associated With Testicular Cancer Proliferation
por: Chen, Ruiqi, et al.
Publicado: (2018)

Regulation of AR mRNA translation in response to acute AR pathway inhibition
por: Somasekharan, Syam Prakash, et al.
Publicado: (2021)

Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer
por: Al-Nakouzi, Nader, et al.
Publicado: (2022)

Long term deficiency of vitamin D in germ cell testicular cancer survivors
por: Nappi, Lucia, et al.
Publicado: (2018)

Subtle Protective Roles of Clusterin in Gastric Metaplasia After Acute Oxyntic Atrophy
por: Vange, Pål, et al.
Publicado: (2018)

Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation
por: Tang, Yong, et al.
Publicado: (2012)

Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer
por: Al Nakouzi, Nader, et al.
Publicado: (2014)

Correction: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation
por: Tang, Yong, et al.
Publicado: (2013)

Clusterin regulates macrophage expansion, polarization and phagocytic activity in response to inflammation in the kidneys
por: Weng, Xiaodong, et al.
Publicado: (2020)

SGOL1 variant B induces abnormal mitosis and resistance to taxane in non-small cell lung cancers
por: Matsuura, Shun, et al.
Publicado: (2013)

Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma
por: Lamoureux, Francois, et al.
Publicado: (2014)

Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury
por: Guo, Jia, et al.
Publicado: (2016)

Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye
por: Bauskar, Aditi, et al.
Publicado: (2015)

Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model
por: Kususda, Y, et al.
Publicado: (2012)

Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration-resistant prostate cancer treated with custirsen
por: Blumenstein, Brent, et al.
Publicado: (2013)

Introduction of Clusterin Gene into Human Renal Cell Carcinoma Cells Enhances Their Resistance to Cytotoxic Chemotherapy through Inhibition of Apoptosis both in vitro and in vivo
por: Hara, Isao, et al.
Publicado: (2001)

The role of Clusterin in cancer metastasis
por: Peng, Mei, et al.
Publicado: (2019)

Clusterin Expression in Colorectal Carcinomas
por: Téllez, Teresa, et al.
Publicado: (2023)

Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancer
por: Shiota, Masaki, et al.
Publicado: (2015)

Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019)

Automated classification and characterization of the mitotic spindle following knockdown of a mitosis-related protein
por: Khushi, Matloob, et al.
Publicado: (2017)

Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell Carcinoma()()
por: Han, Kyung Seok, et al.
Publicado: (2015)

Divergent roles for Clusterin in Lung Injury and Repair
por: Habiel, David M., et al.
Publicado: (2017)

Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway
por: Han, Kyung Seok, et al.
Publicado: (2015)

Se-Methylselenocysteine Inhibits Apoptosis Induced by Clusterin Knockdown in Neuroblastoma N2a and SH-SY5Y Cell Lines
por: Wang, Chao, et al.
Publicado: (2014)

Proapoptotic role of nuclear clusterin in brain
por: Kim, Nayoung, et al.
Publicado: (2011)

Cooperative Stabilization of Transthyretin by Clusterin and Diflunisal
por: Greene, Michael J., et al.
Publicado: (2014)

Urinary Clusterin Is Upregulated in Nephropathia Epidemica
por: Martynova, Ekaterina V., et al.
Publicado: (2018)

Clusterin: a multifaceted protein in the brain
por: Moon, Hee-Jung, et al.
Publicado: (2020)

Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel
por: Hassan, Mohamed K, et al.
Publicado: (2011)

Clusterin Deficiency Predisposes C57BL/6j Mice to Cationic Bovine Serum Albumin-Induced Glomerular Inflammation
por: Sun, Pengcheng, et al.
Publicado: (2020)

Clusterin levels in undernourished SH-SY5Y cells
por: Rodríguez-Rivera, Carmen, et al.
Publicado: (2021)

P-gp and taxanes
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2014)

Mechanisms of Taxane Resistance
por: Maloney, Sara M., et al.
Publicado: (2020)

Genetic analysis of the clusterin gene in pseudoexfoliation syndrome
por: Burdon, Kathryn P., et al.
Publicado: (2008)

Clusterin confers gmcitabine resistance in pancreatic cancer
por: Chen, Qingfeng, et al.
Publicado: (2011)

Clinical significance of clusterin expression in pancreatic adenocarcinoma
por: Jin, Junshuo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5jtu0un9ar4t9km9oegekhlarf